Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0111
+0.0001 (0.91%)
Aug 29, 2025, 4:00 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $13.79 thousand as of September 2, 2025. Its market cap has decreased by -99.75% in one year.
Market Cap
13.79K
Enterprise Value
-1.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 13.79K, a decrease of -99.96%. That is a compound annual growth rate of -82.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2025 | 13.79K | -99.55% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | 32.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |